Calendar ORIC Pharmaceuticals, Inc. Börse Stuttgart

Equities

4TZ

US68622P1093

Market Closed - Börse Stuttgart 07:03:09 02/07/2024 BST 5-day change 1st Jan Change
7 EUR -1.41% Intraday chart for ORIC Pharmaceuticals, Inc. +6.77% -12.88%

Chart calendar ORIC Pharmaceuticals, Inc.

593889edf68e815802c7da277cbf1.HOMZzHpxVYapfAu7LvHvgBk6KlU27K40YiPB83kz3Yw.KdpxgCwuH__wJFj4GKmM0GpJRz0CnpsBIHOugElLldVFtl6rGTlj6Z4MbA~603bf97f7f44956de09de9ba910a25d8

Upcoming events on ORIC Pharmaceuticals, Inc.

07/08/2024 Q2 2024 Earnings Release (Projected)
03/11/2024 Q3 2024 Earnings Release (Projected)
24/03/2025 Q4 2024 Earnings Release (Projected)
11/05/2025 Q1 2025 Earnings Release (Projected)

Past events on ORIC Pharmaceuticals, Inc.

12/06/2024 16:00 Annual General Meeting
10/06/2024 15:40 Goldman Sachs Global Healthcare Conference
05/06/2024 15:30 Jefferies Global Healthcare Conference
06/05/2024 21:05 Q1 2024 Earnings Release
17/04/2024 17:30 Stifel Virtual Targeted Oncology Days Conference
11/04/2024 20:45 Needham Healthcare Conference
09/04/2024 22:30 American Association for Cancer Research Meeting - Abstract Number: 6856
07/04/2024 21:00 American Association for Cancer Research Meeting - Lori Friedman, Ph.D.
07/04/2024 18:30 American Association for Cancer Research Meeting - Abstract Number: 594
13/03/2024 12:00 Leerink Partners Global Biopharma Conference
11/03/2024 20:05 Q4 2023 Earnings Release
21/02/2024 20:00 Citi Oncology Leadership Summit
14/02/2024 17:00 Oppenheimer Healthcare Life Sciences Conference
07/02/2024 15:00 Guggenheim Healthcare Talks Biotechnology Conference
09/01/2024 19:15 JPMorgan Healthcare Conference
12/12/2023 02:00 American Society of Hematology Meeting - Abstract No:4761
11/12/2023 21:30 American Society of Hematology Meeting
28/11/2023 15:25 Evercore ISI HealthCONx Conference
16/11/2023 10:00 Jefferies London Healthcare Conference
06/11/2023 21:10 Q3 2023 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBITDA
Million USD
Released
Forecast
Spread
0,00


-73,2
-59,0
-24.09%
-78,0
-74,5
-4.72%
-90,8
-87,9
-3.25%
-110
-106
-3.63%

-119

EBIT
Million USD
Released
Forecast
Spread
-28,6


-74,2
-57,1
-29.91%
-78,9
-78,6
-0.4%
-91,8
-90,0
-1.98%
-111
-108
-2.39%

-124

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


-73,7
-56,3
-30.93%
-78,7
-77,1
-2.13%
-89,1
-90,0
1.02%
-101
-99,3
-1.38%

-114

Net income
Million USD
Released
Forecast
Spread
0,00


-73,7
-58,4
-26.27%
-78,7
-78,7
0.03%
-89,1
-89,9
0.91%
-101
-99,3
-1.37%

-114

EPS
USD
Released
Forecast
Spread
0,00


-3,36
-3,22
-4.31%
-2,07
-2,08
0.26%
-2,25
-2,25
-0.17%
-1,96
-1,95
-0.67%

-1,72

Announcement Date28/02/2023/03/2121/03/2216/03/2311/03/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00


0,00


0,00

EBITDA
Million USD
Released
Forecast
Spread









-21,9
-22,0
0.58%
-25,4
-23,0
-10.54%
-24,7
-26,0
4.87%
-28,4
-25,0
-13.7%
-31,2
-28,2
-10.36%
-28,7
-31,0
7.29%

-29,3


-30,0


-30,8







EBIT
Million USD
Released
Forecast
Spread
-23,3
-22,6
-3.07%
-20,7
-23,8
12.94%
-25,7
-21,9
-17.08%
-22,1
-22,3
0.64%
-25,7
-23,2
-10.68%
-25,0
-26,6
5.97%
-28,7
-26,3
-9.14%
-31,4
-29,1
-7.82%
-29,0
-31,4
7.68%

-30,2


-31,8


-33,1


-33,7


-34,5

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-23,2
-22,2
-4.33%
-20,3
-24,1
15.7%
-24,8
-21,9
-13.3%
-20,8
-22,5
7.18%
-23,9
-23,1
-3.55%
-22,9
-26,1
12.24%
-25,5
-24,7
-3.04%
-28,3
-27,0
-4.75%
-25,0
-29,5
15.09%

-28,0


-29,8


-31,3


-32,2


-33,2

Net income
Million USD
Released
Forecast
Spread
-23,2
-22,4
-3.39%
-20,3
-23,7
14.42%
-24,8
-21,9
-13.3%
-20,8
-22,5
7.18%
-23,9
-23,1
-3.55%
-22,9
-26,1
12.24%
-25,5
-24,7
-3.04%
-28,3
-27,0
-4.75%
-25,0
-29,5
15.09%

-28,0


-29,8


-31,3


-32,2


-33,2

EPS
USD
Released
Forecast
Spread
-0,59
-0,57
-2.96%
-0,51
-0,60
15.19%
-0,63
-0,56
-13.28%
-0,52
-0,54
3.31%
-0,53
-0,55
3.69%
-0,50
-0,58
13.51%
-0,44
-0,47
5.47%
-0,49
-0,48
-2.37%
-0,37
-0,44
15.73%

-0,41


-0,44


-0,46


-0,48


-0,49

Announcement Date09/05/2211/08/2207/11/2216/03/2308/05/2310/08/2306/11/2311/03/2406/05/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. ORIC Stock
  4. 4TZ Stock
  5. Calendar ORIC Pharmaceuticals, Inc.